Ling Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ling Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Chen Ding
Department of neurology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
1 shared publication - Cong Yang
College of Food Science and Engineering, Northwest A&F University, Yangling 712100, China
1 shared publication Fangjie Ning
College of Food Science and Engineering, Northwest A&F University, Yangling 712100, China
1 shared publicationJun Gong
College of Food Science and Engineering, Northwest A&F University, Yangling 712100, China
1 shared publicationJun Hu
Peking University Shenzhen Hospital, Shenzhen, Guangdong 518004, China
1 shared publication- Kun Xu
Northwest A&F University
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadw8410
Gut microbial-derived indole-3-propionate improves cognitive function in Alzheimer’s disease
Intermittent fasting (IF) offers a potential strategy to counteract Alzheimer’s disease (AD) progression. In our 16-week study on AD transgenic mice, IF positively affected cognitive function and reduced amyloid-β (Aβ) accumulation, verifying the IF’s role in modulating neuroinflammation. Multiomics integration revealed strong links between IF-induced hippocampal gene expression, gut microbiota, and serum metabolites beneficial for cognition. Indole-3-propionic acid (IPA) emerged as a pivotal microbial metabolite. Blocking its neuronal receptor, pregnane X receptor (PXR), abolished IF’s effects. Human data paralleled these findings, showing lower IPA levels in patients with mild cognitive impairment and AD than in controls. IPA supplementation and IPA-producing Clostridium sporogenes reproduced IF’s cognitive benefits, whereas PXR blockade in neurons or disruption of IPA synthesis abrogated them. IPA crossed the blood-brain barrier, exhibited potent anti-inflammatory activity, and suppressed Aβ accumulation, essential for neuroprotection. These results underscore microbial metabolites regulated by IF, particularly IPA, as therapeutic candidates for AD, highlighting the critical role of the gut-brain axis in neurodegeneration.
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadw8410
Top Cited PapersOpen AccessGut microbial-derived indole-3-propionate improves cognitive function in Alzheimer’s disease
Intermittent fasting (IF) offers a potential strategy to counteract Alzheimer’s disease (AD) progression. In our 16-week study on AD transgenic mice, IF positively affected cognitive function and reduced amyloid-β (Aβ) accumulation, verifying the IF’s role in modulating neuroinflammation. Multiomics integration revealed strong links between IF-induced hippocampal gene expression, gut microbiota, and serum metabolites beneficial for cognition. Indole-3-propionic acid (IPA) emerged as a pivotal microbial metabolite. Blocking its neuronal receptor, pregnane X receptor (PXR), abolished IF’s effects. Human data paralleled these findings, showing lower IPA levels in patients with mild cognitive impairment and AD than in controls. IPA supplementation and IPA-producing Clostridium sporogenes reproduced IF’s cognitive benefits, whereas PXR blockade in neurons or disruption of IPA synthesis abrogated them. IPA crossed the blood-brain barrier, exhibited potent anti-inflammatory activity, and suppressed Aβ accumulation, essential for neuroprotection. These results underscore microbial metabolites regulated by IF, particularly IPA, as therapeutic candidates for AD, highlighting the critical role of the gut-brain axis in neurodegeneration.